8 Einträge gefunden

1. Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells

   1. Lennartz, Maximilian
   2. Atug, Dennis
   3. Dwertmann Rico, Sebastian
   4. Reiswich, Viktor
   5. Viehweger, Florian
   6. Büscheck, Franziska
   7. Kluth, Martina

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer

   1. Marx, Andreas
   2. Koopmann, Lena
   3. Höflmayer, Doris
   4. Büscheck, Franziska
   5. Hube-Magg, Claudia
   6. Steurer, Stefan
   7. Eichenauer, Till

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

   1. Höflmayer, Doris
   2. Steinhoff, Amélie
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Burandt, Eike
   7. Tsourlakis, Maria Christina

   2020 - Forschungsinformationssystem des UKE
4. Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

   1. Fraune, Christoph
   2. Yehorov, Serhiy
   3. Luebke, Andreas M
   4. Steurer, Stefan
   5. Hube-Magg, Claudia
   6. Büscheck, Franziska
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
5. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

   1. Minner, Sarah
   2. Lutz, Jannes
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Höflmayer, Doris
   7. Burandt, Eike

   2019 - Forschungsinformationssystem des UKE
6. Random forest-based modelling to detect biomarkers for prostate cancer progression

   1. Toth, Reka
   2. Schiffmann, Heiko
   3. Hube-Magg, Claudia
   4. Büscheck, Franziska
   5. Höflmayer, Doris
   6. Weidemann, Sören
   7. Lebok, Patrick

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
7. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

   1. Steurer, Stefan
   2. Schwemmer, Lara
   3. Hube-Magg, Claudia
   4. Büscheck, Franziska
   5. Höflmayer, Doris
   6. Tsourlakis, Maria Christina
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE
8. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

   1. Luebke, Andreas M
   2. Attarchi-Tehrani, Ali
   3. Meiners, Jan
   4. Hube-Magg, Claudia
   5. Lang, Dagmar S
   6. Kluth, Martina
   7. Tsourlakis, Maria Christina

   2019 - Forschungsinformationssystem des UKE - frei zugänglich